目的：评价静脉滴注伊曲康唑防治兔侵袭性曲霉病的价值。
Objective: To investigate the efficacy of intravenous itraconazole in the treatment and prophylaxis of invasive aspergillosis.
病灶没有强化信号可能提示为曲霉病，因为脑肿瘤大多有强化信号。
Lack of enhancement may suggest the diagnosis of aspergillosis, since most brain tumors enhance.
旨在估计肺结核(ptb)特别是肺空洞形成之后慢性肺曲霉病(CPA)的全球负担。
To estimate the global burden of chronic pulmonary aspergillosis (CPA) after pulmonary tuberculosis (PTB), specifically in cases with pulmonary cavitation.
常规曲霉病诊断方法由于培养能力限制，不能准确测定对唑类药物的耐药水平。
Conventional diagnosis of aspergillosis is limited by poor culture yield, and so the true frequency of azole resistance has been unclear.
侵袭性曲霉病的治疗需要考虑采取适当的抗真菌治疗、可能的手术处理和免疫调节。
Treatment of invasive aspergillosis requires consideration of appropriate antifungal therapy, potential surgical management, and modulation of immunity.
侵袭性曲霉病(IA)在免疫功能不全人群中是最常见危及生命的机会性霉菌感染。
Invasive aspergillosis (IA) is the most common life-threatening opportunistic invasive mould infection in immunocompromised people.
近年来，侵袭性曲霉病发病率不断上升，并成为免疫抑制患者死亡的主要原因之一。
Recently, the incidence of invasive Aspergillosis is on the rise and it has become one of the major death causes in patients with immune function suppression .
曲霉病是免疫低下宿主第二常见的真菌性中枢神经系统感染，仅次于隐球菌引起的感染。
Aspergillosis is the 2nd most common fungal CNS infection in an immunocompromised host after cryptococcus.
目的：评价ELISA法检测半乳甘露聚糖（GM）用于侵袭性曲霉病（IA）诊断的价值。
Objective: To assess the diagnostic value of galactomannan (GM) detection by ELISA in the invasive aspergillosis (IA).
棘球白素在选择侵袭性真菌感染，最显着的侵袭性念珠菌和曲霉病的治疗已经取得了显着的影响。
Echinocandins have made a significant impact in the treatment of select invasive fungal infections, most notably invasive candidiasis and aspergillosis.
新的抗真菌药物、免疫调节疗法和多种联合治疗方案的出现，使得侵袭性曲霉病患者的存活率有了显著提升。
With the emergence of new antifungal agents, immunomodulation intervention and combination therapy, the survival rate of patients with invasive aspergillosis has been improved greatly.
2007年，全球有770万例肺结核，其中估计有372,000例患有慢性肺曲霉病，各地发病数介于欧洲的11,400例和东南亚的145,372例之间。
In 2007, 7.7 million cases of PTB occurred globally, and of them, an estimated 372 000 developed CPA: from 11 400 in Europe to 145 372 in South-East Asia.
2007年，全球有770万例肺结核，其中估计有372,000例患有慢性肺曲霉病，各地发病数介于欧洲的11,400例和东南亚的145,372例之间。
In 2007, 7.7 million cases of PTB occurred globally, and of them, an estimated 372 000 developed CPA: from 11 400 in Europe to 145 372 in South-East Asia.
应用推荐